NEW UREIDE CARBONYL OCTAHYDROQUINOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND APPLICATION THEREOF

PROBLEM TO BE SOLVED: To provide a compound having D2 dopamine receptor agonistic effect and less 5-HTreceptor stimulation effect, which is useful for treatment and prevention of Parkinson disease, restless legs syndrome or hyperprolactinemia.SOLUTION: There is provided an ureide carbonyl octahydroq...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	NISHIMURA TOSHIHIRO, KAMBE HIROKI
Format:	Patent
Sprache:	eng ; jpn
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To provide a compound having D2 dopamine receptor agonistic effect and less 5-HTreceptor stimulation effect, which is useful for treatment and prevention of Parkinson disease, restless legs syndrome or hyperprolactinemia.SOLUTION: There is provided an ureide carbonyl octahydroquinoline derivative represented, for example, by 2, 3 or the like in the following table.SELECTED DRAWING: None 【課題】パーキンソン病、レストレスレッグス症候群又は高プロラクチン血症の治療または予防に有効な、ドパミンＤ２受容体アゴニスト作用を有し、５−ＨＴ２Ｂ受容体刺激作用の少ない化合物の提供。【解決手段】例えば下記表中の２，３等で表される、ウレイドカルボニルオクタヒドロキノリン誘導体。【選択図】なし